By the end of 2019, more than 75% of the world’s prescription medications will be considered under different legislations. The development of regulations to safeguard the pharmaceutical supply chain is evidence of the fact that the pharmaceutical world has woken up to the problems of counterfeit medicines. Ettore Cucchetti at ACG Inspection Systems Pvt. Ltd explains why it is crucial that organisations implement robust serialisation processes to curtail counterfeiting.